Abstract
Data on cell viability have long been obtained from in vitro cytotoxicity assays. Today, there is a focus on markers of cell death, and the MTT cell survival assay is widely used for measuring cytotoxic potential of a compound. However, a comprehensive evaluation of cytotoxicity requires additional assays which measure short and long-term cytotoxicity. Assays which measure the cytostatic effects of compounds are not less important, particularly for newer anticancer agents. This overview discusses the advantages and disadvantages of different non-clonogenic assays for measuring short and medium-term cytotoxicity. It also discusses clonogenic assays, which accurately measure long-term cytostatic effects of drugs and toxic agents. For certain compounds and cell types, the advent of high throughput, multiparameter, cytotoxicity assays, and gene expression assays have made it possible to predict cytotoxic potency in vivo.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Fellows, M.D., and O’Donovan, M.R. (2007) Cytotoxicity in cultured mammalian cells is a function of the method used to estimate it. Mutagenesis 22, 275–280.
Decker, T., and Lohmann-Matthes, M.L. (1988) A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J. Immunol. Methods 115, 61–69.
Korzeniewski, C., and Callewaert, D.M. (1983) An enzyme-release assay for natural cytotoxicity. J. Immunol. Methods 64, 313–320.
Batchelor, R.H., and Zhou, M. (2004) Use of cellular glucose-6-phosphate dehydrogenase for cell quantitation, applications in cytotoxicity and apoptosis assays. Anal. Biochem. 329, 35–42.
Corey M.J., and Kinders, R.J. Methods and compositions for coupled luminescent assays. United States Patent 6,811,990, issued November 2, 2004.
Corey, M.J., et al, (1997) A Very Sensitive Coupled Luminescent Assay for Cytoxicity and Complement-Mediated Lysis. J. Immunol. Methods 207, 43–51.
Tolnai, S.A. (1975) A method for viable cell count. Meth. Cell Science 1, 37–38.
Ahmed, S.A., Gogal, R.M., Jr, and Walsh, J.E. (1994) A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay. J. Immunol. Methods. 170, 211–24.
Perez, R.P., Godwin, A.K., Handel, L.M., and Hamilton, T.C. (1993) A comparison of clonogenic, microtetrazolium and sulforhodamine B assays for determination of cisplatin cytotoxicity in human ovarian carcinoma cell lines. Eur. J. Cancer 29A, 395–399.
Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren J.T., Bokesch, H., Kenney, S., and Boyd, M.R. (1990) A New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 82, 1107–1112.
Borenfreund, E., and Puerner, J.A. Toxicity determined in vitro by morphological alterations and neutral red absorption. (1985) Toxicol. Lett. 24, 119–124.
Lu, B., Kerepesi, L., Wisse, L., Hitchman, K., and Meng, Q.R. (2007) Cytotoxicity and gene expression profiles in cell cultures exposed to whole smoke from three types of cigarettes. Toxicol. Sci. 98, 469–478.
Lasarow, R.M., Isseroff, R.R., and Gomez, E.C. (1992) Quantitative in vitro assessment of phototoxicity by a fibroblast-neutral red assay. J. Invest. Dermatol. 98, 725–729.
Xingfen, Y., Wengai, Z., Ying, Y., Xikun, X., Xiaoping, X., and Xiaohua, T. (2007) Preliminary study on neutral red uptake assay as an alternative method for eye irritation test. AATEX 14, Special Issue, 509–514. Proc. 6th World Congress on Alternatives & Animal Use in the Life Sciences August 21–25, Tokyo, Japan
Putnam, K.P., Bombick, D.W., and Doolittle, D.J. (2002) Evaluation of eight in vitro assays for assessing the cytotoxicity of cigarette smoke condensate. Toxicol. In Vitro. 16, 599–607.
Sperandio, S., Poksay, K., de Belle, I., Lafuente, M.J., Liu, B., Nasir, J., and Bredesen, D.E. (2004) Paraptosis: mediation by MAP kinases and inhibition by AIP-1/Alix. Cell Death Differ. 11, 1066–1075.
Roche Applied Science: Apoptosis, Cell Death, and Cell Proliferation Manual: 3rd edition, page 59.
Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol. Methods, 65, 55–63.
Scudiero, D.A., Shoemaker, R.H., Paul, K.D., Monks, A., Tierney, S., Nofziger, T.H., Currens, M.J., Seniff, D., and Boyd, M.R. (1988) Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 48, 4827–4833.
Crouch, S.P., Kozlowski, R., Slater, K.J., and Fletcher, J. (1993) The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. J. Immunol. Methods. 160, 81–88.
Petty, R.D., Sutherland, L.A., Hunter, E.M., and Cree, I.A. (1995) Comparison of MTT and ATP-based assays for the measurement of viable cell number. J. Biolumin. Chemilumin. 10, 29–34.
Ulukaya, E., Ozdikicioglu, F., Oral, A.Y., and Demirci, M. (2008) The MTT assay yields a relatively lower result of growth inhibition than the ATP assay depending on the chemotherapeutic drugs tested. Toxicol. In Vitro 22, 232–239.
Ng, T.Y., Ngan, H.Y., Cheng, D.K., and Wong, L.C. (2000) Clinical applicability of the ATP cell viability assay as a predictor of chemoresponse in platinum-resistant epithelial ovarian cancer using nonsurgical tumor cell samples. Gynecol. Oncol. 76, 405–408.
Tam, K.F., Ng, T.Y., Liu, S.S., Tsang, P.C.K., Kwong, P.W.K., and Ngan, H.Y.S. (2005) Potential application of the ATP cell viability assay in the measurement of intrinsic radiosensitivity in cervical cancer.Gynecol. Oncol. 96, 765–770.
Roche Applied Science: Apoptosis, Cell Death, and Cell Proliferation Manual: 3rd edition, page 98.
Hynes, J., Hill, R., and Papkovsky, D.B. (2006) The use of a fluorescence-based oxygen uptake assay in the analysis of cytotoxicity. Toxicol. In Vitro 5, 785–792.
Lindhagen, E., Nygren, P., and Larsson, R. (2008) The fluorometric microculture cytotoxicity assay. Nat. Protoc. 3, 1364–1369.
Mickuviene, I., Kirveliene, V., and Juodka, B. (2004) Experimental survey of non-clonogenic viability assays for adherent cells in vitro. Toxicol. In Vitro 18, 639–648.
Ivanova, L., and Uhlig, S. (2008) A bioassay for the simultaneous measurement of metabolic activity, membrane integrity, and lysosomal activity in cell cultures. Anal. Biochem. 379, 16–19.
Elmore, S. (2007) Apoptosis: A Review of Programmed Cell Death. Toxicologic Pathology 35, 495–516.
Gurtu, V., Kain, S.R., and Zhang, G. (1997) Fluorometric and colorimetric detection of caspase activity associated with apoptosis. Anal Biochem, 251, 98–102.
Grabarek, J., Amstad, P., and Darzynkiewicz, Z. (2002). Use of fluorescently labeled caspase inhibitors as affinity labels to detect activated caspases. Hum Cell, 15, 1–12.
Bossy-Wetzel, E., and Green, D.R. (2000) Detection of apoptosis by Annexin V labeling. Methods Enzymol, 322, 15–18.
Wyllie, A.H. (1980) Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284, 555–556.
Rubin, R.L., Joslin, F.G., and Tan, E.M. (1983) An improved ELISA for anti-native DNA by elimination of interference by anti-histone antibodies. J. Immunol. Methods 63, 359–366.
Kressel, M., and Groscurth, P. (1994) Distinction of apoptotic and necrotic cell death by in situ labelling of fragmented DNA. Cell Tissue Res, 278, 549–556.
Poot, M., and Pierce, R.H. (1999) Detection of changes in mitochondrial function during apoptosis by simultaneous staining with multiple fluorescent dyes and correlated multiparameter flow cytometry. Cytometry, 35, 311–317.
Scorrano, L., Ashiya, M., Buttle, K., Weiler, S., Oakes, S.A., Mannella, C.A., and Korsmeyer, S.J. (2002) A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis. Dev. Cell, 2, 55–59.
Goldstein, J.C., Waterhouse, N.J., Juin, P., Evan, G.I., and Green, D.R. (2000). The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant. Nat. Cell Biol. 2, 156–162.
Roper, P.R., and Drewinko, B. (1976) Comparison of in vitro methods to determine drug-induced cell lethality. Cancer Res, 36 (7 PT 1), 2182–2188.
Jarvis, W.D., Fornari, F.A., Traylor, R.S., Martin, H.A., Kramer, L.B., Erukulla, R.K., Bittman, R., and Grant, S. (1996) Induction of apoptosis and potentiation of ceramide-mediated cytotoxicity by sphingoid bases in human myeloid leukemia cells. J. Biol. Chem. 271, 8275–8284.
Yalkinoglu, A.O., Schlehofer, J.R., and zur Hausen, H. (1990). Inhibition of N-methyl-N’-nitro-N-nitrosoguanidine-induced methotrexate and adriamycin resistance in CHO cells by adeno-associated virus type 2. Int. J. Cancer. 45, 1195–1203.
Cordes, N., and Meineke, V. (2003) Cell adhesion-mediated radioresistance (CAM-RR): Extracellular matrix-dependent improvement of cell survival in human tumor and normal cells in vitro. Strahlenther. Onkol. 179, 337–344.
Herzog, E., Casey, A., Lyng, F.M., Chambers, G., Byrne, H.J., and Davoren, M. (2007) A new approach to the toxicity testing of carbon-based nanomaterials: the clonogenic assay. Toxicol. Lett. 174, 49–60.
Mirzayans, R., Andrais, B., Scott, A., Tessier, A., and Murray, D. (2007) A sensitive assay for the evaluation of cytotoxicity and its pharmacologic modulation in human solid tumor-derived cell lines exposed to cancer-therapeutic agents. J. Pharm. Pharm. Sci. 10, 298s–311s.
Stroncek, D.F., Jin, P., Wang, E., and Jett, B. (2007) Potency analysis of cellular therapies: the emerging role of molecular assays. J. Transl. Med. 5, 24–29.
Duerst, R.E., and Frantz, C.N. (1985) A sensitive assay of cytotoxicity applicable to mixed cell populations. J. Immunol. Methods 82, 39–46.
Frgala, T., Kalous, O., Proffitt, R.T., and Reynolds, C.P. (2007) A fluorescence microplate cytotoxicity assay with a 4-log dynamic range that identifies synergistic drug combinations. Mol. Cancer Ther. 6, 886–897.
Aragon, V., Chao, K., and Dreyfus, L.A. (1997) Effect of cytolethal distending toxin on F-actin assembly and cell division in Chinese hamster ovary cells. Infect Immun. 65, 3774–3780.
Sacks, P.G., Harris, D., and Chou, T.C. (1995) Modulation of growth and proliferation in squamous cell carcinoma by retinoic acid: a rationale for combination therapy with chemotherapeutic agents. Int. J. Cancer 61, 409–415.
Schoonen, W.G., Walter, M.A., Westerink, W.M., and Horbach, G.J. (2009) High-throughput screening for analysis of in vitro toxicity. Mol. Clin. Environ. Toxicol. 99, 401–452.
Xia, M., Huang. R., Witt, K.L., Southall, N., Fostel, J., Cho, M.H., Jadhav, A., Smith, C.S., Inglese, J., Portier, C.J., Tice, R.R., and Austin, C.P. (2008) Compound cytotoxicity profiling using quantitative high-throughput screening. Environ. Health Perspect. 116, 284–291.
O’Brien, P.J., Irwin, W., Diaz, D., Howard-Cofield, E., Krejsa, C.M., Slaughter, M.R., Gao, B., Kaludercic, N., Angeline, A., Bernardi, P., Brain, P., and Hougham, C. (2006) High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening. Arch. Toxicol, 80, 580–604.
Yang, S.T., Zhang, X., and Wen, Y. (2008) Microbioreactors for high-throughput cytotoxicity assays. Curr. Opin. Drug. Discov. Devel. 1, 111–127.
Sivaraman, A., Leach, J.K., and Townsend, S., Hogan, B.J., Stolz, D.B., Fry, R., Samson, L.D., Tannenbaum, S.R., and Griffith, L.G. (2005) A microscale in vitro physiological model of the liver: predictive screens for drug metabolism and enzyme induction. Curr. Drug Metab. 6, 569–591.
Lee, M.Y., Kumar, R.A., Sukumaran, S.M., Hogg, M.G., Clark, D.S., and Dordick, J.S. (2008) Three-dimensional cellular microarray for high-throughput toxicology assays. Proc. Natl. Acad. Sci. U. S. A. 105, 59–63.
Baudoin, R., Griscom, L., and Monge, M., et al. (2007) Development of a renal microchip for in vitro distal tubule models. Biotechnol. Prog. 23, 1245–1253.
Walker, G.M., Monteiro-Riviere, N., Rouse, J. and O’Neill, A.T. (2007) A linear dilution microfluidic device for cytotoxicity assays. Lab Chip. 7, 226–232.
Cui, Z. F., Xu, X., Trainor, N., Triffitt, J. T., Urban, J. P. G., and Tirlapur, U. K. (2007) Application of multiple parallel perfused microbioreactors and three-dimensional stem cell culture for toxicity testing. Toxicol. In Vitro. 21, 1318–1324.
Viravaidya, K., Sin, A. and Shuler, M.L. (2004) Development of a microscale cell culture analog to probe naphthalene toxicity. Biotechnol. Prog. 20, 316–323.
Li, A.P., Bode, C. and Sakai, Y. (2004) A novel in vitro system, the integrated discrete multiple organ cell culture (IdMOC) system, for the evaluation of human drug toxicity: comparative cytotoxicity of tamoxifen towards normal human cells from five major organs and MCF-7 adenocarcinoma breast cancer cells. Chem. Biol. Interact. 150, 129–136.
Anderson, E.J. and Knothe-Tate, M.L. (2007) Open access to novel dual flow chamber technology for in vitro cell mechanotransduction, toxicity and pharmacokinetic studies. BioMedical Engineering Online, 6, 46–57.
Gerhold, D., Lu, M., Xu, J., Austin, C., Caskey, C.T., and Rushmore, T. (2001) Monitoring expression of genes involved in drug metabolism and toxicology using DNA microarrays. Physiol. Genomics. 5, 161–170.
Slatter, J.G., Cheng, O., Cornwell, P.D., de Souza, A., Rockett, J., Rushmore, T., Hartley, D., Evers, R., He, Y., Dai, X., Hu, R., Caguyong, M., Roberts, C.J., Castle, J., and Ulrich, R.G. (2006) Microarray-based compendium of hepatic gene expression profiles for prototypical ADME gene-inducing compounds in rats and mice in vivo. Xenobiotica 36, 902–937.
Bartosiewicz, M., Trounstine, M., Barker, D., Johnston, R., and Buckpitt, A. (2000) Development of a toxicological gene array and quantitative assessment of this technology. Arch. Biochem. Biophys. 376, 66–73.
Ishida, S., Shigemoto-Mogami, Y., Kagechika. H., Shudo, K., Ozawa, S., Sawada, J., Ohno, Y., and Inoue, K. (2003) Clinical potential of subclasses of retinoid synergists revealed by gene expression profiling. Mol. Cancer. Ther. 2, 49–58.
Glaysher, S., Yiannakis, D., Gabriel, F.G., Johnson, P., Polak, M.E., Knight, L.A., Goldthorpe, Z., Peregrin, K., Gyi, M., Modi, P., Rahamim, J., Smith, M.E., Amer, K., Addis, B., Poole, M., Narayanan, A., Gulliford, T.J., Andreotti, P.E., and Cree, I.A. (2009) Resistance gene expression determines the in vitro chemosensitivity of non-small cell lung cancer (NSCLC). BMC Cancer 9, 300.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Sumantran, V.N. (2011). Cellular Chemosensitivity Assays: An Overview. In: Cree, I. (eds) Cancer Cell Culture. Methods in Molecular Biology, vol 731. Humana Press. https://doi.org/10.1007/978-1-61779-080-5_19
Download citation
DOI: https://doi.org/10.1007/978-1-61779-080-5_19
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-079-9
Online ISBN: 978-1-61779-080-5
eBook Packages: Springer Protocols